MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States
Clinical trial NCT00121108 · COMPLETED
Trial details
- NCT number
- NCT00121108
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-15
- Primary completion
- 2010-12-27
- Enrollment
- 2127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.